Anadrol Inj 50 mg

Anadrol Inj 50 mg contains oxymetholone, which is FDA-approved for treating anemias caused by deficient red cell production, including aplastic anemia and anemias related to myelotoxic drugs. In non-medical bodybuilding contexts, oxymetholone is commonly referenced for rapid mass and strength gains during bulking phases, though such use falls outside approved medical indications.

In medical settings, oxymetholone is typically dosed once daily or in divided doses based on body weight and clinical response. Because the compound has a short half-life of approximately 8–9 hours, non-medical use often involves splitting the daily dose into two or three administrations to maintain more stable blood levels.

Oxymetholone suppresses endogenous testosterone production, so in non-medical bodybuilding contexts, post-cycle therapy is commonly recommended after any cycle involving this compound. Agents such as Clomid or Nolvadex are commonly referenced for this purpose.

Oxymetholone is an anabolic steroid that enhances the production and urinary excretion of erythropoietin in patients with anemias due to bone marrow failure, and often stimulates erythropoiesis in anemias due to deficient red cell production. It also promotes nitrogen retention and protein synthesis. Non-medical use for bodybuilding falls outside approved indications.

In medical settings for anemia, response to oxymetholone is not immediate and a minimum trial of three to six months is typically recommended. In non-medical bodybuilding contexts, users often report noticeable strength and weight gains within the first two weeks, though individual response varies.

There is no single oral steroid that is universally best. Oxymetholone is among the most potent oral anabolics for mass and strength, but it is also associated with significant hepatotoxicity and side effects. Other orals such as Dianabol 20 and Winstrol 10 have different potency, side effect, and aromatization profiles.

Both oxymetholone and methandienone are potent 17-alpha-alkylated oral anabolic steroids commonly referenced for bulking. Methandienone is aromatizable, meaning it converts to estrogen and can cause estrogenic side effects through that pathway. Oxymetholone is not directly aromatized but is still associated with estrogenic effects through less understood mechanisms. Oxymetholone is generally considered more hepatotoxic.

Oxymetholone and stanozolol are both oral 17-alpha-alkylated anabolic steroids, but they have different profiles. Oxymetholone is primarily used for bulking and mass gain, with significant water retention and hepatotoxicity. Stanozolol is more commonly referenced for cutting phases, as it does not aromatize and is associated with leaner, drier gains.

In medical settings, oxymetholone dosing is individualized by body weight, typically ranging from 1–5 mg/kg per day. For a 100 kg patient, 50 mg would represent 0.5 mg/kg, which is below the usual effective medical range. In non-medical bodybuilding contexts, 50 mg per day is often referenced as a starting point, with experienced users sometimes using higher doses. Any use carries hepatotoxic risk.

Anadrol Inj 50 mg is labeled at 50 mg of oxymetholone per mL. It is supplied in a 10 mL vial, giving 500 mg of total labeled oxymetholone content per vial.

Yes. A published laboratory report dated October 5, 2024 measured Anadrol Inj 50 mg at 55.27 mg/mL, equivalent to 110.54% of its 50 mg/mL label claim. The complete report can be viewed in the Lab Reports tab.

Estrogenic effects such as gynecomastia and water retention are commonly reported in non-medical users of oxymetholone. Although oxymetholone is not directly aromatized to estrogen, the mechanism behind this effect is not fully understood. Management in non-medical contexts sometimes involves aromatase inhibitors or SERMs, though medical guidance is advised.